Literature DB >> 24200061

[Effect of tanshinone II A on the expressions of NeuN, GFAP and CD11b in Aβ1-42; induced newborn rat hippocampal slices in vitro].

Li Zhou1, Jun Zhou, Yanping Liu.   

Abstract

OBJECTIVE: To detect the expressions of neuron-specific nuclear protein (NeuN), glial fibrillary acidic protein (GFAP) and CD11b in the Aβ1-42 induced newborn rat hippocampal slices in vitro and investigate the neuroprotective effect of tanshinone IIA.
METHODS: Hippocampal slices were randomly divided into 7 groups: normal control group; Aβ1-42 (5.0, 0.5 μg/mL) groups; Aβ (5.0 μg/mL) + low or high (8.0 mg or 16 mg) doses of Tan IIA groups, Aβ (0.5 μg/mL) + low or high (8.0 mg or 16 mg) doses of Tan IIA groups. The expression levels of GFAP, NeuN and CD11b were detected by immunohistochemistry.
RESULTS: Compared with the control group, the expression of NeuN decreased in the two different doses of Aβ1-42 groups, especially in the high-dose group (P<0.05); while the level significantly increased after high-dose Tan IIA treatment (P<0.05). Compared with the control group, the expression levels of GFAP and CD11b increased in the two different doses of Aβ1-42 groups, and the levels in the high-dose group were the highest (P<0.05); while the levels were reduced significantly by Tan IIA treatment, the more by the high-dose Tan IIA (P<0.05).
CONCLUSION: Tan IIA can down-regulate the levels of GFAP and CD11b and inhibit the activity of glial cells in rat hippocampal slices induced by Aβ1-42 in vitro.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200061

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  Tanshinone IIA Inhibits β-Catenin Nuclear Translocation and IGF-2R Activation via Estrogen Receptors to Suppress Angiotensin II-Induced H9c2 Cardiomyoblast Cell Apoptosis.

Authors:  Ya-Fang Chen; Cecilia Hsuan Day; Nien-Hung Lee; Yu-Feng Chen; Jaw-Ji Yang; Chih-Hsueh Lin; Ray-Jade Chen; Peramaiyan Rajendran; Vijaya Padma Viswanadha; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2017-09-30       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.